Agilent Technologies, Inc.

Agilent Technologies empowers scientists globally with advanced analytical, research, and diagnostic solutions, accelerating progress in areas like cancer treatment, drug discovery, infectious disease research, environmental and medical safety, and alternative energy development. Our global teams design and manufacture cutting-edge tools, while the unique expertise of our CrossLab and technical teams provides invaluable support to optimize laboratory resources and bring great science to life. Agilent Technologies reported revenues of $6.85 billion in fiscal 2022.